Mylan Tests Novo's Wegovy Patents as States Target Chinese GLP-1 Supply
Monday, September 28, 2026 · 7 min
Mylan is asking a Delaware court to clear its proposed generic Wegovy from a new Novo Nordisk patent. Twenty state attorneys general are warning the White House about Chinese GLP-1 ingredient suppliers, and doctors are flagging a rare vision-loss risk still under study.
Listen
Show notes
Mylan is asking a Delaware court to clear its proposed generic Wegovy from a new Novo Nordisk patent. Twenty state attorneys general are warning the White House about Chinese GLP-1 ingredient suppliers, and doctors are flagging a rare vision-loss risk still under study.
In this episode
- Mylan asks US court to clear Wegovy generic from Novo patent claims | Reuters — Reuters
Mylan asks US court to clear Wegovy generic from Novo patent claims | Reuters Skip to main content Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv Subscribe # Mylan asks US court to clear Wegovy generic from Novo patent claims By Blake Brittain September 25, 20267:23 PM UTCUpdated ago Text * Small Text * Medium Text * Large…
- Step Back — Mylan is asking a court to clear a Wegovy generic from Novo Nordisk’s patent claims—what would a win actually change for patients, and why wouldn’t it automatically mean a generic could appear immediately?
Background sources
- Mylan asks US court to clear Wegovy generic from Novo patent claims | Reuters — Blake Brittain
- Mylan Wants Del. Judge To Clear Wegovy Generic Drug - Law360 — Law360
- Novo Nordisk, Inc. v. Mylan Pharm. Inc. (792 F.Supp.3d 536) - vLex United States — Vlex
- Novo, Mylan Jockey Over Trial Timing in Wegovy Patent Dispute — Bloomberglaw
- Mylan seeks declaratory judgment against Novo Nordisk over newly issued Wegovy patent, aiming to preempt a new Delaware lawsuit – ip fray — Ipfray
- Tennessee AG Skrmetti Joins 20-State Warning over Chinese Weight-Loss Drug Suppliers Linked to Fentanyl Precursors - Tennessee Star — Tennessee Star
Tennessee AG Skrmetti Joins 20-State Warning over Chinese Weight-Loss Drug Suppliers Linked to Fentanyl Precursors - Tennessee Star # Tennessee AG Skrmetti Joins 20-State Warning over Chinese Weight-Loss Drug Suppliers Linked to Fentanyl Precursors September 25, 2026 Tom Pappert Tennessee Attorney General Jonathan Skrmetti announced this week that his office joined 19 other state attorneys…
- Doctor warns of 'eye stroke' risk linked to GLP-1 weight loss drugs - Health - News - Daily Express US — Daily Express US
Doctor warns of 'eye stroke' risk linked to GLP-1 weight loss drugs - Health - News - Daily Express US ## Despite the risk, doctors are warning that diabetes and obesity still have proven health risks if gone untreated. By Cheyenne R. Ubiera 15:11 ET, Sun, Sep 27, 2026 Updated: 15:11 ET, Sun, Sep 27, 2026 Doctors are warning of a rare eye condition linked to GLP-1 drugs (Image: Corbis via…